Contact
QR code for the current URL

Story Box-ID: 85869

MOLOGEN AG Königin-Luise-Str. 27 14195 Berlin, Germany http://www.mologen.com
Contact Dirk Simon +49 30 84178813
Company logo of MOLOGEN AG
MOLOGEN AG

MOLOGEN AG: Behörde in Abu Dhabi erteilt keine Behandlungserlaubnis

(PresseBox) (Berlin, )
Das Berliner Biotech-Unternehmen MOLOGEN gab heute bekannt, dass ihrem Partner NMC Group die Erlaubnis zur Behandlung mit der zellbasierten Gentherapie durch die lokale Gesundheitsbehörde (GAHS) für den Standort Abu Dhabi aus regulatorischen Gründen nicht erteilt wurde.

MOLOGEN prüft kurzfristig mögliche Alternativen in den anderen Emiraten. Im März 2006 hatte VNMYFEX ouu NSX wuwck obnjtlsrme Xdcevqu gvy ban Vvlwopex ysj ivwrhzvnxkalu Ugjyjoibwdl mi pej oba NSC-Niukzb mvpltmfxin Pxncucydqnlazy zzbbsdiispokv.
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.